Sustained Weight Loss After Treatment With a Glucagon-Like Peptide-1 Receptor Agonist in an Obese Patient With Schizophrenia and Type 2 Diabetes

被引：22
作者：
Ishoy, Pelle L. [1 ]
Knop, Filip K.
Vilsboll, Tina
Glenthoj, Birte Y.
Ebdrup, Bjorn H.
机构：
[1] Univ Copenhagen, Ctr Clin Intervent & Neuropsychiat Schizophrenia, Fac Hlth Sci, Psychiat Ctr Glostrup,Glostrup Hosp, Glostrup, Denmark
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2013年 / 170卷 / 06期
关键词：
D O I：
10.1176/appi.ajp.2013.12101344
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：681 / 682
页数：2
相关论文
共 3 条
[1]   Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits [J].
Ebdrup, Bjorn H. ;
Knop, Filip K. ;
Ishoy, Pelle L. ;
Rostrup, Egill ;
Fagerlund, Birgitte ;
Lublin, Henrik ;
Glenthoj, Birte .
BMC MEDICINE, 2012, 10
[2]   A systematic review of mortality in schizophrenia - Is the differential mortality gap worsening over time? [J].
Saha, Sukanta ;
Chant, David ;
McGrath, John .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (10) :1123-1131
[3]   Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials [J].
Vilsboll, Tina ;
Christensen, Mikkel ;
Junker, Anders E. ;
Knop, Filip K. ;
Gluud, Lise Lotte .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
1